<DOC>
	<DOCNO>NCT02741219</DOCNO>
	<brief_summary>The purpose multicenter study evaluate effectiveness safety dexmedetomidine combine sufentanil patient-controlled analgesia caesarean section</brief_summary>
	<brief_title>A Multicenter Study : Dexmedetomidine Combined With Sufentanil Patient Controlled Intravenous Analgesia After Caesarean Section</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>1 . Parturients undergo elective caesarean delivery spinal anaesthesia 2 . American Society Anesthesiologists class I II parturients age 1845 year , term singleton pregnancies 3 . Parturients ability understand verbal write mandarin 4 . Parturients want use PCA intravenous analgesia use pump correctly 5 . Parturients whose write informed consent obtain 1 . A history allergy dexmedetomidine study drug 2 . A long use history opioid analgesic , NSAIDs , tranquilliser use 3 . Psychiatric disorder 4 . A history neuromuscular endocrine disease allergic disease 5 . A history lower abdominal surgery 6 . Preoperative heart rate ( HR ) less 50 bpm , SBP le 100 mmHg cardiac conduction rhythm abnormalities 7. spinal anaesthesia unsuccessful epidural catheter use achieve adequate anaesthesia 8 . A second operation require study . 9 . Participating study late three month 10 . Body mass index 30 kg/m2 11 . Difficult airway ( Mallampati score 3 anatomic deformity ) 12 . Not suitable participation estimate investigation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>